Answers are grounded in this paper and cite their sources.
Identifies biological pathways associated with psychometabolic risk in middle-aged women, suggesting new avenues for research.
Introduction and Objective: The bidirectional relationship between T2D and depression is well-established, with women at higher risk of co-occurrence (psychometabolic risk). The menopausal transition that occurs in midlife is period of elevated risk for both conditions. While co-expressed microRNAs (miRs) are associated with psychometabolic risk in women during midlife, evidence on biological pathways regulated by these miRs is limited. Methods: This study included the subset of middle aged (50 ± 9 years) women with miR data in the Diabetes Prevention Program (DPP) trial (n=675). Our prior study used principal components (PC) analysis to identify miR co-expression networks associated with high psychometabolic risk. In this study, miRTarBase was used to identify mRNAs targeted by miRs with the highest PC weights and then pathway enrichment analysis was performed. Results: There were 71 pathways with overrepresentation of mRNAs targeted by at least three of the top 10 weighted miRs in the PC associated with high psychometabolic risk. See figure for pathways organized thematically by mRNA. Conclusion: This study, focused on high psychometabolic risk in women during midlife, identified biological themes of metabolism, inflammation, and endocrine activity and provided new evidence for a theme of stress/biological weathering. These insights provide a foundation for future studies aimed at delineating life stage-specific mechanisms underlying psychometabolic risk in women. Disclosure K.D. Longoria: None. B.M. Stroebel: None. M. Gadgil: Advisory Panel; Ended; LumosFit.
No takes yet. Share an insight, caveat, or question.
Longoria et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: